Anti Obesity Drugs Market Scope And Analysis

  • Report Code : TIPRE00006850
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 310
Buy Now

Anti-obesity Drugs Market Analysis, Size, and Growth (2025-2031)

Buy Now

Anti-obesity Drugs Market Report Anti-obesity Drugs Market Size and Share Anti-obesity Drugs Market Scope and Analysis

Anti-obesity Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ 15.85 Billion
Market Size by 2031 US$ 177.27 Billion
Global CAGR (2025 - 2031) 35.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Prescription
  • OTC
By Drug Class
  • GLP-1 Agonist
  • Lipase Inhibitors
  • MC4R agonist
By Application
  • Appetite Suppression
  • Inhibition of Fat Absorption/Digestive Enzymes
  • Metabolic Enhancement
  • Combination
By Route of Administration
  • Oral
  • Parenteral
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novo Nordisk AS
  • Eli Lilly and Co
  • GSK Plc
  • Rhythm Pharmaceuticals Inc
  • Currax Pharmaceuticals LLC
  • VIVUS LLC
  • AdvaCare Pharma USA LL
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • F Hoffmann La Roche Ltd
    		•